Clicky

Allergy Therapeutics(AGYTF)

Description: Allergy Therapeutics plc engages in the research and development of allergy treatments. It sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies, particularly to grasses, weeds, and trees. The company's products include Pollinex, Pollinex Quattro, Oralvac, Acarovac Plus, and Venomil. It also develops clinical pipeline products that include vaccines for grass, tree, and house dust mite, as well as a peanut allergy vaccine that is in pre-clinical stage. The company primarily sells its products in European countries. Allergy Therapeutics plc was founded in 1934 and is based in Worthing, the United Kingdom.


Keywords: Medicine Immunology Immune System Vaccines Allergy Immunotherapies Trees Allergies Peanut Allergology Allergen Grasse Allergy Treatment Food Allergies Hal Allergy Group Allergy Therapeutics Peanut Allergy

Home Page: www.allergytherapeutics.com

Dominion Way
Worthing, BN14 8SA
United Kingdom
Phone: 44 1903 844 700


Officers

Name Title
Mr. Manuel Llobet CEO & Exec. Director
Mr. Martin Hopcroft Interim Chief Financial Officer
Ms. Beverly Lees Group Operations Director
Dr. Murray Skinner Chief Scientific Officer
Mr. Santiago Puig Bus. Devel. Director
Ms. Sue Baker Head of HR
Simon Piggott Head of Clinical Science
Alan Bullimore Head of Communication & Market Devel.
Mr. Russell Picket Group Financial Controller
Sara Goldsbrough Company Sec.

Exchange: PINK

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 2.2491
Price-to-Sales TTM: 1.4559
IPO Date:
Fiscal Year End: June
Full Time Employees: 600
Back to stocks